|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/117 | |
| A61K 31/7125 | |||
| A61P 9/10 | |||
| A61K 31/7088 |
| (11) | Number of the document | 2342341 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09825058.2 |
| Date of filing the European patent application | 2009-10-28 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-03-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2009/051227 |
| Date | 2009-10-28 |
| (87) | Number | WO 2010/053430 |
| Date | 2010-05-14 |
| (30) | Number | Date | Country code |
| 111284 P | 2008-11-04 | US | |
| 0802338 | 2008-11-04 | SE |
| (72) |
ADMYRE, Charlotte, SE
AXELSSON, Lars-Göran, SE
VON STEIN, Oliver, SE
ZARGARI, Arezou, SE
|
| (73) |
Index Pharmaceuticals AB,
Tomtebodavägen 23 a, plan 6, 171 65 Stockholm,
SE
|
| (54) | COMPOUNDS AND METHODS FOR REDUCING THE RECRUITMENT AND/OR MIGRATION OF POLYMORPHONUCLEAR CELLS |
| COMPOUNDS AND METHODS FOR REDUCING THE RECRUITMENT AND/OR MIGRATION OF POLYMORPHONUCLEAR CELLS |